Health Care Down Slightly, But Sector Holds Hefty 2019 Gains

Health-care companies ticked down but the sector remained one of the strongest performers on the Standard & Poor’s 500 for the year to date.

The Food and Drug Administration on Monday said it has approved two applications for the first generic version of the blood thinner Eliquis by Mylan and Micro Labs.

Liquidia Technologies rose sharply after the early-stage biotech company raised about $22.4 million in a private placement stock sale to fund development of a blood-pressure treatment.

https://www.marketscreener.com/MYLAN-N-V-21077045/news/Health-Care-Down-Slightly-But-Sector-Holds-Hefty-2019-Gains-Health-Care-Roundup-29769405/